Home › Ischemic Stroke › Michigan › Detroit
Ischemic Stroke clinical trials in Detroit, MI
5 studies for Ischemic Stroke are looking for participants at sites in and around Detroit (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
RecruitingPhase 3
- Henry Ford Health, Detroit
The Fourth Left Atrial Appendage Occlusion Study
Recruiting
- Henry Ford Health System, Detroit
- Henry Ford Health System, Detroit
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
RecruitingPhase 2
- Henry Ford Hospital, Detroit
Michigan Initial Experience Using Tigertriever for Thrombectomy
RecruitingObservational study
- Henry Ford Hospital, Detroit
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
Recruiting
- Henry Ford Health System, Detroit
About Ischemic Stroke
A stroke is a medical emergency that should be treated immediately. Read about the causes, symptoms and treatments for an ischemic stroke.
More about Ischemic Stroke on MedlinePlus
Ischemic Stroke trials in other cities
- New York City, NY18 studies
- Houston, TX18 studies
- Boston, MA17 studies
- Los Angeles, CA14 studies
- Philadelphia, PA13 studies
- Atlanta, GA13 studies
- Chicago, IL12 studies
- Baltimore, MD11 studies
- Pittsburgh, PA11 studies
- Cincinnati, OH11 studies
- St. Louis, MO11 studies
- Salt Lake City, UT10 studies
Other studies in Detroit
- Non-Small Cell Lung Cancer44 studies
- Breast Cancer33 studies
- Cancer (all types)29 studies
- Colorectal Cancer26 studies
- Ovarian Cancer26 studies
- Metastatic Cancer24 studies
- Prostate Cancer22 studies
- Endometrial Cancer21 studies
- Lung Cancer20 studies
- Multiple Myeloma19 studies
- Stomach Cancer16 studies
- Head and Neck Squamous Cell Carcinoma15 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.